Accelerator Startup BioXplor combines artificial intelligence with big data to accelerate drug discovery

Overview

In his interview with startuprad.io we get to know Pavel from startup BioXplor, one of our startups within the 6th Accelerator intake, and learn about his journey to revolutionize drug discovery.

Publish Date

07 MAY 2018

In his interview with startuprad.io we get to know Pavel from startup BioXplor, one of our startups within the 6th Accelerator intake, and learn about his journey to revolutionize drug discovery. BioXplor is an intelligence platform which generates data-driven hypotheses and novel predictions in biomarker and drug discovery. The computer-based discovery platform is built on the intersection of big data, artificial intelligence and high-performance computing, and works by enabling accelerated data interpretations from unstructured literature and structured multi-omics data. Learn more about their exciting journey by watching the full interview! 

 

 


Enjoyed the read?

To keep up to date with all new happenings at our Innovation Center, click here to subscribe to our e-mail service.

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement